KR20030090243A - Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes - Google Patents

Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes Download PDF

Info

Publication number
KR20030090243A
KR20030090243A KR1020020028267A KR20020028267A KR20030090243A KR 20030090243 A KR20030090243 A KR 20030090243A KR 1020020028267 A KR1020020028267 A KR 1020020028267A KR 20020028267 A KR20020028267 A KR 20020028267A KR 20030090243 A KR20030090243 A KR 20030090243A
Authority
KR
South Korea
Prior art keywords
kccm
bacillus subtilis
fibrin
solution
enzyme
Prior art date
Application number
KR1020020028267A
Other languages
Korean (ko)
Inventor
김경남
김현수
김태석
태수길
Original Assignee
주식회사풀무원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사풀무원 filed Critical 주식회사풀무원
Priority to KR1020020028267A priority Critical patent/KR20030090243A/en
Publication of KR20030090243A publication Critical patent/KR20030090243A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus
    • C12R2001/125Bacillus subtilis ; Hay bacillus; Grass bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: A microorganism Bacillus subtilis DM185(KCCM-10372) producing a fibrin lysis enzyme is provided. The microorganism can mass-produce the fibrin lysis enzyme which can prevent various circulatory diseases caused by excess fibrin. CONSTITUTION: A microorganism Bacillus subtilis DM185(KCCM-10372) producing a fibrin lysis enzyme is provided, wherein Bacillus subtilis DM185(KCCM-10372) is isolated by collecting samples from salted seafood, diluting the samples in 0.85% physiological saline solution, heating the diluted solution at 85 deg. C for 30 minutes, diluting the heat treated solution in 0.85% physiological saline solution by stages, spreading the diluted solution on a nutrient agar medium, culturing the medium at 37 deg. C for 48 hours, isolating colonies grown, dropping the isolated colony cultured medium on a fibrin plate, and selecting one strain showing the excellent fibrin lysis activity.

Description

혈전용해효소를 생산하는 바실러스 서브틸리스 디엠185(케이씨씨엠-10372) 미생물 {Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes}Bacillus subtilis DM185 (KCCM-10372) which produces fibrinolytic enzymes}

본 발명은 혈전용해효소를 생산하는 바실러스 서브틸리스(Bacillus subtilis) 미생물에 관한 것이다.The present invention relates to Bacillus subtilis microorganisms producing thrombolytic enzymes.

혈전용해효소는 단백질분해효소의 일종으로 플라스민(Plasmin)과 마찬가지로 세린(serine) 계열의 알칼라인 프로테아제(alkaline protease)이다. 이러한 효소류는 전통발효식품의 제조과정 중 바실러스 속의 균주에 의해 생성되며 이런 발효 식품류를 섭취함으로써 혈전증의 예방 및 치료에 효과를 줄 수 있다는 가정 아래 많은 연구가 진행되고 있다. 혈전은 생체 내의 반응 중 자연스럽게 생성과 분해가 평형을 이루고 있는 대사과정의 산물로 혈액응고와 관련이 있다. 혈전의 생성은 손상된 혈관 내피 세포에 혈소판이 부착하여 피브린(fibrin)을 형성하면서 시작된다. 혈전의 생성 원인은 아직까지 정확히 알려진 바는 없으나The thrombolytic enzyme is a kind of protease and, like Plasmin, is an alkaline protease of the serine family. These enzymes are produced by strains of the genus Bacillus during the manufacturing process of traditional fermented foods, and many studies are being conducted under the assumption that ingestion of such fermented foods can have an effect on the prevention and treatment of thrombosis. Thrombus is a product of metabolic processes that naturally produce and degrade equilibrium during reactions in vivo, and is related to blood coagulation. The production of thrombi begins when platelets adhere to damaged vascular endothelial cells to form fibrin. The cause of thrombus formation is not yet known.

파종성혈관내응고병증(disseminated intravascular coagulation) 같은 선천적 유전질환, 신체의 노화에 따른 생리적 기능의 변화, 스트레스 등이 그 원인으로 거론되고 있으며, 특히 현대인의 과다한 업무로 인한 스트레스는 혈액 응고기전에 관여하는 인자의 양에 변화를 일으켜 비정상적인 혈전을 일으키는 원인 중의 하나로 지목되고 있다. 이러한 혈액 내의 과다한 혈전으로 인해 야기되는 질병인 혈전증은 인체에 치명적인 손상을 야기시킬 수 있다.Congenital genetic diseases such as disseminated intravascular coagulation, changes in physiological function according to aging of the body, and stress are cited as causes. Especially, stress caused by excessive work of modern people is involved in blood clotting. It is considered as one of the causes of abnormal thrombus by changing the amount of the factor. Thrombosis, a disease caused by excessive blood clots in the blood, can cause fatal damage to the human body.

혈전증의 치료를 위해 사용되는 치료제로는 현재, 항혈전제로서 유기합성제제인 쿠마린(coumarin), 와파린(warfarin) 제제, 거머리에서 생성되는 히루딘(hirudin) 제제가 사용되고 있고, 혈전용해제로는 유로키나제(urokinase), 스트렙토키나제(streptokinase), 티슈 타입 플라스미노겐 활성인자(tissue-type plasminogen activator) 등이 일반적인 치료제로 사용되고 있으나 이러한 치료제들은 비경제적이고, 유로키나제를 제외하고는 경구투여가 어려운 문제점들을 가지고 있다.Therapeutic agents used for the treatment of thrombosis are currently used as anti-thrombotic agents such as coumarin, coumarin, warfarin, and hirudin, which are produced from leeches. (urokinase), streptokinase, and tissue-type plasminogen activator are commonly used as treatments, but these treatments are inexpensive and have difficulty in oral administration except for urokinase. .

따라서, 본 발명은 한국 고유의 전통식품인 젓갈에서 혈전용해효소를 생산하는 미생물을 분리 및 선발하여, 활성이 높고 안정한 효소를 생산하는 미생물을 제공하는 데 있다.Accordingly, the present invention is to provide a microorganism that produces a highly active and stable enzyme by isolating and selecting microorganisms producing thrombolytic enzymes in salted fish, which is a Korean traditional food.

제 1도는 피브리노겐을 0.7% 함유한 피브린 플레이트 상에 바실러스 서브틸리스 DM185(KCCM-10372) 배양액을 50 마이크로리터 점적하여 섭씨 37도에서 16시간 반응시켰을 때 생성된 투명환을 나타낸 도면FIG. 1 is a diagram showing a clear ring formed when 50 microliters of Bacillus subtilis DM185 (KCCM-10372) culture solution was added to a fibrin plate containing 0.7% fibrinogen and reacted at 37 ° C. for 16 hours.

제 2도는 TSA 고체배지(Tryptic Soy Agar)상에 바실러스 서브틸리스 DM185(KCCM-10372)를 획선배양하여 섭씨 37도에서 48시간 배양하였을 때 형성된 균락의 형태를 나타낸 도면2 is a diagram showing the morphology of the fungi formed when the Bacillus subtilis DM185 (KCCM-10372) was cultured on TSA solid medium (Tryptic Soy Agar) and cultured for 48 hours at 37 degrees Celsius.

발명에 사용된 시료Sample used in the invention

본 발명에 사용된 사료는 우리 나라 서울 및 서울 근교지역의 가정에서 직접 담근 김치와 장류, 국내에서 제조된 다양한 종류의 젓갈을 시료로 사용하였다.The feed used in the present invention used kimchi and soy sauce dipped in homes in Seoul and suburbs of Korea, as well as various types of salted salted seafood.

시료에서 균의 분리Isolation of bacteria from the sample

병원성 세균들을 배제하고, 내열성 포자생성균을 분리하기 위하여, 약 1 그램 정도의 시료를 취하여 100 밀리리터의 0.85% 생리식염수에 현탁한 후, 섭씨 85도에서 30분간 열처리를 하였다. 열처리가 끝난 현탁액을 0.85%의 생리식염수에 단계적으로 희석하여 영양한천배지(Nutrient agar) 상에 도말하였다. 도말한 영양한 천배지를 섭씨 37도에서 48시간 동안 배양한 후에 생성된 균락을 백금이로 취하여 영양한천배지 상에 획선도말 한 후, 순수한 균락들이 관찰될 때 까지 순수분리 하였다.In order to exclude pathogenic bacteria and to isolate heat-resistant spore-producing bacteria, approximately 1 gram of sample was taken and suspended in 100 milliliters of 0.85% saline, and then heat-treated at 85 degrees Celsius for 30 minutes. The heat treated suspension was serially diluted in 0.85% saline and plated on Nutrient agar. After incubating the plated nutrient agar for 48 hours at 37 degrees Celsius, the resulting bacterium was taken as platinum and streaked on a nutrient agar medium, followed by pure separation until pure colonies were observed.

분리균주에 대한 혈전용해 활성 측정Measurement of thrombolytic activity against isolated strain

혈전용해 활성이 우수한 균주를 선발하기 위한 탐색방법으로서, 피브린 플레이트 상에 균주의 배양액을 일정량 점적하여 반응시킨 후, 투명환의 생성 유무를 확인하였다. 피브린 플레이트 상에서 혈전용해효소를 생산하는 균주의 배양액을 첨가하여 반응시킬 경우, 피브린이 효소에 의해 용해되면서 배양액 주위로 투명환이 생기게 된다. 따라서 각각의 분리 균주들에 대해, 균주들의 배양액을 피브린 플레이트에 가하여 반응시킨 후, 투명환의 생성을 관찰함으로써 혈전용해효소를 생산하는 균주를 선발할 수 있다고 판단되었다.As a screening method for selecting strains having excellent thrombolytic activity, a predetermined amount of the culture solution of the strains was added and reacted on a fibrin plate, and then the presence or absence of the formation of a transparent ring was confirmed. When the reaction solution is added with a culture solution of a strain that produces a thrombolytic enzyme on the fibrin plate, the fibrin is dissolved by the enzyme and a clear ring is formed around the culture solution. Therefore, for each of the isolated strains, it was determined that strains that produce thrombolytic enzymes can be selected by adding cultures of the strains to the fibrin plates and reacting them, and then observing the production of clear rings.

[실시예 1]Example 1

혈전용해효소를 생산하는 균주를 선발하는 실험으로, 피브린 플레이트를 이용한 방법을 활용하였다. 순수하게 분리된 균주들을 10 밀리리터의 영양배지(Nutrient broth)에 접종하여 섭씨 37도에서 24시간 동안 교반배양한 후, 배양액을 취하여 원심분리하여 균체를 제거한 후 얻어진 상등액을 효소활성을 측정하기 위한 시료로 사용하였다. 피브리노겐(Fibrinogen) 0.7 그램을 취하여 인산완충액(10 mM, pH 7.4) 100 밀리리터에 녹인 후, 여과지로 여과하여 페트리디쉬에 10 밀리리터 씩 분주하여 트롬빈(thrombin, 100 NIH unit)을 100 마이크로리터 씩 넣고 잘 섞어서 실온에서 방치하여 응고시켰다. 응고된 피브린 플레이트 상에 종이 디스크를 올려놓고, 조효소액을 50 마이크로리터에서 100 마이크로리터 씩 접종하여 섭씨 37도에서 16시간 정도 반응시킨 후 용해된 투명환의 직경을 측정하였다.As an experiment for selecting strains that produce thrombolytic enzymes, a method using fibrin plates was used. Purely isolated strains were inoculated in 10 milliliters of Nutrient broth, stirred and incubated for 24 hours at 37 degrees Celsius, and cultured to remove the cells by centrifugation. Used as. Take 0.7 grams of fibrinogen, dissolve in 100 milliliters of phosphate buffer (10 mM, pH 7.4), filter with filter paper, and dispense 10 milliliters into Petri dishes. Add 100 microliters of thrombin (100 NIH units). Mix and leave at room temperature to solidify. A paper disk was placed on the coagulated fibrin plate, and the coenzyme solution was inoculated at 50 microliters to 100 microliters and reacted for 16 hours at 37 degrees Celsius, and then the diameter of the dissolved transparent ring was measured.

생성된 투명환의 직경이 큰 균주들을 혈전용해 활성이 우수한 균주로 1차 선발하였으며, 그 형태는 도 1과 같았다.Strains with large diameters of the resulting transparent rings were first selected as strains with excellent thrombolytic activity, and their forms were as shown in FIG. 1.

[실시예 2]Example 2

1차로 선발된 균주들에 대해 보다 정확한 혈전용해 효소의 활성을 측정하기 위해 튜빙 방법을 사용하였다. 시험관에 1.4 밀리리터의 0.05 몰 Borate 완충액(pH 8.5, NaCl 포함)과 0.4 밀리리터의 피브리노겐 용액(0.72%)을 첨가 혼합하여 섭씨 37도의 항온수조에서 5분간 정치시킨 후, 트롬빈 용액(1000 unit/ml)을 100 마이크로리터 첨가하여 잘 혼합한 후 섭씨 37도의 항온수조에서 10분간 반응시켰다. 응고된 반응용액에 측정하고자 하는 조효소액을 100 마이크로리터 첨가하여 혼합한 후 섭씨 37도의 항온수조에서 1시간 동안 반응시켰다. 반응 1시간 경과 후 0.2 몰 트리클로로아세트산 용액을 2 밀리리터 첨가하여 반응을 중지시켰다. 트리클로로아세트산 용액을 첨가한 후 섭씨 37도의 항온수조에서 20분간 더 반응시킨 후 반응액을 1 밀리리터 취하여 15,000 rpm에서 5분간 원심분리를 실시하였다. 원심분리가 끝난후 상등액을 조심스럽게 취하여 275 nm에서 흡광도를 측정하였다. 얻어진 흡광도치를 대조구와 비교하여 효소활성을 계산하였다. 효소활성이 가장 우수한 균주를 최종 선발하여 이를 DM185라 명명하였으며, 그 효소활성은 표 1과 같았다.The tubing method was used to determine the more accurate activity of thrombolytic enzymes for the primary selected strains. 1.4 ml of 0.05 mol Borate buffer (pH 8.5, NaCl) and 0.4 ml of fibrinogen solution (0.72%) were added to the test tube and allowed to stand for 5 minutes in a 37 ° C constant temperature water bath, followed by a thrombin solution (1000 unit / ml). 100 microliters of the mixture was mixed well and then reacted for 10 minutes in a constant temperature water bath at 37 degrees Celsius. 100 microliters of the crude enzyme solution to be measured was added to the coagulated reaction solution, followed by reaction for 1 hour in a constant temperature water bath at 37 degrees Celsius. After 1 hour of reaction, 2 ml of a 0.2 mol trichloroacetic acid solution was added to stop the reaction. After adding trichloroacetic acid solution, the reaction mixture was further reacted in a constant temperature water bath at 37 degrees Celsius for 20 minutes, and then 1 milliliter of the reaction solution was centrifuged at 15,000 rpm for 5 minutes. After centrifugation, the supernatant was carefully taken and the absorbance was measured at 275 nm. Enzyme activity was calculated by comparing the obtained absorbance value with the control. The final strain was selected as the best enzyme activity was named DM185, the enzyme activity is shown in Table 1.

표 1. 배양 시간별 DM185의 효소 활성Table 1. Enzyme activity of DM185 by incubation time

최종 선발된 균주인 DM185를 TSA 고체한천배지(Tryptic Soy Agar) 상에 획선 배양하여 섭씨 37도에서 48시간 배양한 후 생성된 균락을 관찰하였으며, 그 형태는 도 2와 같았다.DM185, the final selected strain, was cultured on a TSA solid agar medium (Tryptic Soy Agar) and cultured for 48 hours at 37 degrees Celsius, and the resulting colonies were observed.

선발균주의 동정 및 생화학 테스트Identification and Biochemistry Testing of Selected Bacteria

효소 활성이 가장 높은 균주로 최종 선발된 균주인 DM185(KCCM-10372) 대해 생화학적 특성과 당이용성, 세포막 지방산 조성비를 이용해서 동정을 실시하였다.DM185 (KCCM-10372), the final strain selected as the highest enzyme activity, was identified using biochemical properties, sugar availability, and membrane fatty acid composition ratio.

[실시예 3]Example 3

DM185(KCCM-10372)에 대해 형태적, 생리적, 생화학적 실험을 한 결과는 표 2와 같았다.Morphological, physiological and biochemical experiments on DM185 (KCCM-10372) are shown in Table 2.

표 2. DM185(KCCM-10372)의 형태적, 생리적, 생화학적 특성Table 2. Morphological, Physiological and Biochemical Properties of DM185 (KCCM-10372)

상기 표 2에서 나타난 결과로 미루어 보아 선발된 본 균주는 바실러스속(Bacillus sp.)으로 간주되었다.Based on the results shown in Table 2, the selected strain was considered as Bacillus sp.

[실시예 4]Example 4

바실러스 속으로 간주된 이 선발균주에 대하여 API 50CHB 킷트(API bioMerieux, France)를 이용해 49종의 당발효 시험을 실시한 결과는 다음의 표 3과 같다.The sugar fermentation test of 49 strains considered to be of the genus Bacillus using API 50CHB kit (API bioMerieux, France) was performed as shown in Table 3 below.

표 3. DM185(KCCM-10372)의 당발효 시험 결과Table 3. Sugar Fermentation Test Results of DM185 (KCCM-10372)

표 3. 이어서Table 3. Then

표 3. 이어서Table 3. Then

[실시예 5]Example 5

균주의 세포막 지방산 성분을 분석하기 위해 Microbial Identification System(MIDI; Microbial ID, Inc., Newark, Delaware, U.S.A)의 분석방법을 사용하였다. 균주의 세포막 지방산 분석을 위해서, 우선 가스 크로마토그래피(GC) 전처리 과정을 행하였다. 분리주를 BHI 한천배지 상에서 섭씨 28도에서 24시간 동안 획선 배양한 후, 형성된 균락들을 수집하여 얻어진 펠렛에 메탄올에 현탁시킨 수산화나트륨 용액으로 비누화 과정을 수행하였다. 이를 다시 메탄올에 현탁시킨 6M 농도의 염산용액으로 메틸화 과정을 거친 후, hexane과 methyl-tert-butyl ether로 추출하고, 수산화나트륨 용액으로 세척하였다. 세척과정이 끝난 유기용매층을 취하여 GC vial로 옮긴 후, 가스크로마토그래피 분석을 통하여 준비한 미생물 시료가 가지고 있는 methyl ester fatty acid 내의 연소되는 탄소를 측정하여 미생물 동정의 자료로 사용하였다. 실험 균주 내 지방산 함량과 데이터베이스 내에 저장되어 있는 identification library를 비교함으로써 균주의 동정을 시도하였다. 이 선발균주의 세포막 지방산 성분을 분석한 결과는 표 4에 나타난 바와 같다.In order to analyze the cell membrane fatty acid component of the strain, an analysis method of Microbial Identification System (MIDI; Microbial ID, Inc., Newark, Delaware, U.S.A) was used. For cell membrane fatty acid analysis of the strain, gas chromatography (GC) pretreatment was first performed. The isolates were incubated for 24 hours at 28 degrees Celsius on a BHI agar medium, and then the resulting colonies were subjected to a saponification process with sodium hydroxide solution suspended in methanol in the resulting pellets. This was again methylated with 6M hydrochloric acid solution suspended in methanol, extracted with hexane and methyl-tert-butyl ether, and washed with sodium hydroxide solution. After the washing process, the organic solvent layer was taken, transferred to GC vial, and the burned carbon in methyl ester fatty acid of microbial sample prepared by gas chromatography was used as data for microorganism identification. The strain was identified by comparing the fatty acid content in the experimental strain and the identification library stored in the database. The results of analysis of the cell membrane fatty acid component of the starter strain are shown in Table 4.

표 4. DM185(KCCM-10372)의 세포막 지방산 성분Table 4. Cell Membrane Fatty Acid Components of DM185 (KCCM-10372)

상기의 형태학적, 생리적, 생화학적, 당발효 특성 및 세포막 지방산 성분 분석을 통하여 본 선발균주인 DM185(KCCM-10372)는 바실러스 서브틸리스(Bacillus subtilis)로 동정되었다.Based on the morphological, physiological, biochemical, glycofermentative properties and cell membrane fatty acid component analysis, DM185 (KCCM-10372) was selected as Bacillus subtilis.

선발균주의 배양 조건에 따른 효소 활성Enzyme Activity According to Culture Conditions of Selected Strains

바실러스 서브틸리스 DM185(KCCM-10372)의 배양 조건에 따른 효소 활성을 조사하기 위해 배양 온도 및 pH, 배양배지 등을 달리하면서 효소 활성을 측정하였다.In order to investigate the enzyme activity according to the culture conditions of Bacillus subtilis DM185 (KCCM-10372) enzyme activity was measured by varying the culture temperature, pH, culture medium and the like.

[실시예 6]Example 6

바실러스 서브틸리스 DM185(KCCM-10372)의 배양배지에 따른 효소 활성을 조사하기 위한 실험을 수행하였다. 바실러스 서브틸리스 DM185(KCCM-10372)를 5종의 배지에 각각 접종하여 배양한 후, 각각의 배양액을 취하여 원심분리하여 균체를 제거한 후 각각에 대한 효소활성을 측정하였다. 배양 조건은 섭씨 30도씨에서 36시간 동안 진탕배양하였으며, 각 배양배지의 배지조성과 각각에 대한 효소 활성은 표 5에 나타난 바와 같다. 이 때 효소활성 측정은 피브린 플레이트 방법을 사용하였으며, 효소 활성은 이미 알고 있는 역가의 표준효소(Plasmin, 100 unit/ml)를 같은 조건에서 반응시켜 생성된 투명환 직경의 상대적인 비율로 결정하였다.An experiment was conducted to investigate the enzyme activity according to the culture medium of Bacillus subtilis DM185 (KCCM-10372). Bacillus subtilis DM185 (KCCM-10372) was inoculated in each of five media, followed by incubation, and each culture was taken, and centrifuged to remove cells. Culture conditions were shaken for 36 hours at 30 degrees Celsius, culture medium composition and enzyme activity for each is shown in Table 5. At this time, the enzyme activity was measured using the fibrin plate method, and the enzyme activity was determined as a relative ratio of the diameter of the transparent ring generated by reacting a known standard enzyme (Plasmin, 100 unit / ml) under the same conditions.

표 5. 바실러스 서브틸리스 DM185에 대한 배양배지 조성과 효소 활성Table 5. Culture medium composition and enzyme activity for Bacillus subtilis DM185

위의 표 5에서 나타난 결과와 같이 LB 액체배지에서 배양하였을 때 가장 높은 효소 활성을 나타내었다.As shown in Table 5 above, it showed the highest enzyme activity when cultured in LB liquid medium.

[실시예 7]Example 7

바실러스 서브틸리스 DM185(KCCM-10372)의 배양온도에 따른 효소 활성을 조사하기 위한 실험을 수행하였다. 바실러스 서브틸리스 DM185(KCCM-10372)를 LB 액체배지에서 2회 계대배양한 후, 배양온도를 달리하여 배양한 후, 배양액을 취하여 원심분리하여 균체를 제거한 후, 상등액의 효소 활성을 측정하였다. 효소 활성 측정은 피브린 플레이트 방법을 사용하였으며, 기존의 알고 있는 역가의 표준효소(Plasmin, 100 unit/ml)를 같은 조건에서 반응시켜 형성된 투명환 직경의 상대적인 비율로 결정하였다. 각 배양온도별 효소 활성은 표 6에 나타난 바와 같다.An experiment was conducted to investigate the enzyme activity according to the culture temperature of Bacillus subtilis DM185 (KCCM-10372). Bacillus subtilis DM185 (KCCM-10372) was passaged twice in LB liquid medium, and then cultured at different incubation temperatures. The culture medium was taken, centrifuged to remove cells, and the enzyme activity of the supernatant was measured. Enzyme activity was measured using the fibrin plate method, and was determined by the relative ratio of the diameter of the transparent ring formed by reacting a standard enzyme of known titer (Plasmin, 100 unit / ml) under the same conditions. Enzyme activity for each culture temperature is shown in Table 6.

표 6. 바실러스 서브틸리스 DM185(KCCM-10372)의 배양온도에 따른 효소활성Table 6. Enzymatic Activities of Bacillus Subtilis DM185 (KCCM-10372) According to Incubation Temperature

위의 표 6에서 나타난 바와 같이 섭씨 35도 근방에서 배양하였을 때 가장 높은 효소활성을 나타내었다.As shown in Table 6 above, the highest enzymatic activity was obtained when cultured at around 35 degrees Celsius.

[실시예 7]Example 7

바실러스 서브틸리스 DM185(KCCM-10372)의 배양 pH에 따른 효소활성을 조사하기 위한 실험을 수행하였다. pH를 달리하여 조제한 각각의 LB 액체배지에 바실러스 서브틸리스 DM185(KCCM-10372) 접종하여 섭씨 30도에서 48시간 동안 교반배양하였다. 배양이 끝난 배양액을 취하여 원심분리를 통해 균체를 제거한 후, 상등액의 효소활성을 측정하였다. 효소 활성 측정은 피브린 플레이트 방법을 사용하였으며, 기존의 알고 있는 역가의 표준효소An experiment was conducted to investigate the enzyme activity according to the culture pH of Bacillus subtilis DM185 (KCCM-10372). Bacillus subtilis DM185 (KCCM-10372) was inoculated into each LB liquid medium prepared at different pHs, and stirred cultured at 30 ° C. for 48 hours. After culturing, the culture solution was taken, cells were removed by centrifugation, and the enzyme activity of the supernatant was measured. Enzyme activity was measured using the fibrin plate method, and standard enzymes of known titers

(Plasmin, 100 unit/ml)를 같은 조건에서 반응시켜 형성된 투명환 직경의 상대적인 비율로 결정하였다. 각 배양 pH별 효소 활성은 표 7에 나타난 바와 같다.(Plasmin, 100 unit / ml) was determined by the relative ratio of the diameter of the transparent ring formed by the reaction under the same conditions. Enzyme activity for each culture pH is shown in Table 7.

표 7. 바실러스 서브틸리스 DM185(KCCM-10372)의 배양 pH별 효소 활성Table 7. Enzyme Activity by Culture pH of Bacillus subtilis DM185 (KCCM-10372)

위의 표 7에서 나타난 바와 같이 초기 pH가 8.0 근방일 때 가장 높은 효소활성을 나타내었다.As shown in Table 7, the highest enzyme activity was shown when the initial pH was around 8.0.

한국 전통발효식품인 젓갈에서 분리한 바실러스 서브틸리스 DM185(KCCM-10372)는 기존의 보고된 균주들 대비 높은 역가의 혈전용해효소를 생산하는 것으로 나타났다.Bacillus subtilis DM185 (KCCM-10372), isolated from Korean traditional fermented food, has been shown to produce higher titers of thrombolytic enzymes than previously reported strains.

이 미생물이 생산하는 혈전용해효소를 효소제제나 기타 건강보조식품의 원료로 사용하여 한국인에 적합한 산업적으로 가치있는 고품질의 제품을 생산할 수 있고, 제품 품질 및 국제 경쟁력에서의 비교우위를 점할 수 있다.The thrombolytic enzyme produced by this microorganism can be used as a raw material for enzyme preparations or other dietary supplements to produce industrially valuable high-quality products suitable for Koreans, and have a comparative advantage in product quality and international competitiveness.

Claims (1)

혈전을 용해하는 활성을 지닌 효소를 생산하는 바실러스 서브틸리스 DM185(KCCM-10372) 미생물Bacillus subtilis DM185 (KCCM-10372) microorganism producing enzymes with activity to dissolve blood clots
KR1020020028267A 2002-05-21 2002-05-21 Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes KR20030090243A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020020028267A KR20030090243A (en) 2002-05-21 2002-05-21 Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020028267A KR20030090243A (en) 2002-05-21 2002-05-21 Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes

Publications (1)

Publication Number Publication Date
KR20030090243A true KR20030090243A (en) 2003-11-28

Family

ID=32383865

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020028267A KR20030090243A (en) 2002-05-21 2002-05-21 Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes

Country Status (1)

Country Link
KR (1) KR20030090243A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04370093A (en) * 1991-06-19 1992-12-22 Asahi Shokuhin Kogyo Kk Production of thrombolytic substance
JPH06153977A (en) * 1992-11-16 1994-06-03 Japan Energy Corp Production of protein having fibrinolytic activity
KR950008682A (en) * 1993-09-16 1995-04-19 김규식 Bacillus sp. CK 11-4 (KCCM 10042), a new strain that produces thrombolytic enzymes
KR0180103B1 (en) * 1996-03-27 1999-04-01 정영기 Thrombosis dissolution enzyme from bacillus subtilis
KR20020071646A (en) * 2001-03-07 2002-09-13 (주)윌바이오텍 Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component
KR100370796B1 (en) * 2002-04-20 2003-02-05 주식회사 쎌앤젠 Bacillus subtilis CG-1 and Lactobacillus delbrueckii CG-2, and the preparation of fermented soybean by mixed culture of them
KR20030084073A (en) * 2002-04-24 2003-11-01 주식회사 바이오알앤즈 Novel strain bacillus sp. brd-54(kctc 10183bp) and method for preparing thrombolytic enzyme protein from the microorgarnism

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04370093A (en) * 1991-06-19 1992-12-22 Asahi Shokuhin Kogyo Kk Production of thrombolytic substance
JPH06153977A (en) * 1992-11-16 1994-06-03 Japan Energy Corp Production of protein having fibrinolytic activity
KR950008682A (en) * 1993-09-16 1995-04-19 김규식 Bacillus sp. CK 11-4 (KCCM 10042), a new strain that produces thrombolytic enzymes
KR0180103B1 (en) * 1996-03-27 1999-04-01 정영기 Thrombosis dissolution enzyme from bacillus subtilis
KR20020071646A (en) * 2001-03-07 2002-09-13 (주)윌바이오텍 Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component
KR100370796B1 (en) * 2002-04-20 2003-02-05 주식회사 쎌앤젠 Bacillus subtilis CG-1 and Lactobacillus delbrueckii CG-2, and the preparation of fermented soybean by mixed culture of them
KR20030084073A (en) * 2002-04-24 2003-11-01 주식회사 바이오알앤즈 Novel strain bacillus sp. brd-54(kctc 10183bp) and method for preparing thrombolytic enzyme protein from the microorgarnism

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Korean Soc. Food Sci. Nutr. 1998 27(1);51-56. (53)쪽 표1참조 *

Similar Documents

Publication Publication Date Title
Chantawannakul et al. Characterization of proteases of Bacillus subtilis strain 38 isolated from traditionally fermented soybean in Northern Thailand
Wang et al. Screening of a high fibrinolytic enzyme producing strain and characterization of the fibrinolytic enzyme produced from Bacillus subtilis LD-8547
Chandrasekaran et al. Exploring the in vitro thrombolytic activity of nattokinase from a new strain Pseudomonas aeruginosa CMSS
KR20130071345A (en) Novel bacillus sp. microorganiam having thrombolytic activity, culture fluid thereof, thrombolytic peptide produced thereby, thrombolytic composition containging thereof and producing method of the same
JP6800950B2 (en) Bacillus subtilis strain with high production of thrombolytic enzyme
Joshi Purification and characterization of a novel protease from Bacillus firmus Tap5 isolated from tannery waste
Abdelghani et al. Isolation and mutagenesis of streptokinase producing bacteria
Obeid et al. Isolation and characterization of bacillus subtillus with potential production of nattokinase
Sneha et al. Isolation and screening of protease producing bacteria from marine waste
Eldeen et al. Optimization of culture conditions to enhance nattokinase production using RSM
KR100779267B1 (en) Bacillus subtilis NNT-0701 and chongkukjang prepared using it
KR20030090243A (en) Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes
KR100670499B1 (en) Bacillus subtilis BB-1
Ferdiani et al. Characteristics and Substrate Specificity of Semi-Purified Bacterial Protease of Bacillus thuringiensis HSFI-12 with Potential as Antithrombotic Agent
KR0180103B1 (en) Thrombosis dissolution enzyme from bacillus subtilis
KR100511637B1 (en) Novel strain bacillus sp. brd-54(kctc 10183bp) and thrombolytic enzyme protein from the microorgarnism
KR100189660B1 (en) Thrombolysis enzyme from bacillus sp.
Zakaria et al. Screening and identification of fibrinolytic bacteria from malaysian fermented seafood products
Amid et al. Fibrinolytic Enzyme
Hamzah et al. Physiological regulation of protease and antibiotics in Penicillium sp. using submerged and solid state fermentation techniques
JP3532503B2 (en) Processed food and food processing method
Almengor-Hecht et al. Continuous-flow enrichment of a strain of Erwinia carotovora having specificity for highly methylated pectin
Umar et al. Production of Fibrinolytic Enzyme by Soil Actinobacteria: Production of Fibrinolytic Enzyme by Soil Actinobacteria
Gond et al. Agro Waste Mediated Production of Fibrinolytic Enzyme and Its Optimization and Application
Alakbaree et al. In-vitro characterization of thrombolytic activity of staphylokinase produced by Staphylococcus aureus S1

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application